ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Lupus and lupus nephritis"

  • Abstract Number: 643 • 2019 ACR/ARP Annual Meeting

    Association Between Neutrophil to Lymphocyte, Monocyte to Lymphocyte, and Platelet to Lymphocyte Ratios and Lupus Disease Activity and Lupus Nephritis

    Philip Carlucci1, Elliot Luttrell-Williams 1, Rohit Bhan 1, Catherine Trad 1, Hanane El Bannoudi 1, Peter Izmirly 1, H. Michael Belmont 2, Jill Buyon 3 and Jeffrey Berger 1, 1New York University School of Medicine, New York, 2New York University School of Medicine, Ney York, 3New York University School of Medicine, New York, NY

    Background/Purpose: Subjects with Systemic Lupus Erythematosus (SLE) are at elevated risk for end-organ damage. Lupus nephritis continues to be the complication with the highest standardized…
  • Abstract Number: 2583 • 2019 ACR/ARP Annual Meeting

    Prevalence and Risk Factors of Herpes Zoster Reactivation in Patients with Biopsy Proven Lupus Nephritis Undergoing Immunosuppressive Therapies

    Chi Chiu Mok1, Kar Li Chan 2, Sau Mei Tse 2 and Ling Yin Ho 2, 1Department of Medicine, Tuen Mun Hospital, Hong Kong, China (People's Republic), 2Tuen Mun Hospital, Hong Kong, Hong Kong

    Background/Purpose: To study the prevalence of Herpes Zoster (HZ) reactivation in patients with biopsy confirmed lupus nephritis (LN) undergoing immunosuppressive therapies.Methods: Patients who had biopsy…
  • Abstract Number: 2658 • 2018 ACR/ARHP Annual Meeting

    Real World Medication Use in Incident Systemic Lupus Erythematosus and Lupus Nephritis Patients

    Lin Xie1, Furaha Kariburyo1, Janvi Sah1, Jennifer Lofland2 and Nan Li3, 1STATinMED Research Inc., Ann Arbor, MI, 2Janssen Scientific Affairs, LLC, Horsham, PA, 3Janssen Research & Development, LLC, Spring House, PA

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease that causes inflammation in connective tissues and can involve multiple organs systems. Lupus nephritis (LN) is…
  • Abstract Number: 1640 • 2017 ACR/ARHP Annual Meeting

    SLICC Damage Index Is Associated with Tubulointerstitial Nephritis on Lupus Nephritis Biopsies

    Cianna Leatherwood, Brigham and Women's Hospital, Boston, MA

    SLICC Damage Index is associated with Tubulointerstitial Nephritis on Lupus Nephritis BiopsiesKristin D’ Silva, Paul Hoover, Gearoid McMahon, Sushrut Waikar, Helmut Rennke, Karen Costenbader Background/Purpose:…
  • Abstract Number: 598 • 2013 ACR/ARHP Annual Meeting

    Gender Influence On Lupus Nephritis Outcomes In An Urban, Multiethnic Population

    Cindy Johnston, Catarina Vila-Inda and Irene Blanco, Rheumatology, Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: Systemic lupus erythematosus (SLE) is a disease predominately of young women that disproportionately affects minorities.   Lupus Nephritis (LN) causes major morbidity and mortality in…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology